article thumbnail

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation

Recommendations from the “2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” and the “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” have been updated with new evidence to guide clinicians.

article thumbnail

Focus on EP | A Practical Primer For the 2023 AFib Guideline

American College of Cardiology

One of my New Year's resolutions was to read the entire 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (AFib).

AFIB 40
article thumbnail

Medtronic LINQ Insertable Cardiac Monitors Prove Cost-effective Compared to Standard of Care in Ischemic Stroke Patients with Suspected Atrial Fibrillation

DAIC

in 2014 and is available worldwide. Results will be presented at the American Heart Association/American Stroke Association ( AHA / ASA ) International Stroke Conference ( ISC ) 2024 in Phoenix. ii] The cost-effectiveness analysis reflects data from 492 patients in the STROKE AF study, which was conducted across 33 centers in the U.S.

article thumbnail

Age-stratified patterns in clinical presentation, treatment and outcomes in acute pericarditis: a retrospective cohort study

Heart BMJ

Methods Patients with a first episode of acute pericarditis were consecutively enrolled between January 2014 and June 2022, and divided into four groups according to age (G1: 18–35 years; G2: 35–55 years; G3: 55–75 years; G4: >75 years). A secondary cause of pericarditis was detected in 128/471 (27.2%) patients.

article thumbnail

Biosense Webster Announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation (PFA) Platform

DAIC

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). Atrial Fibrillation. Circulation.

article thumbnail

Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort

Open Heart

Aims Direct-acting oral anticoagulants (DOACs) have, to a substantial degree, replaced vitamin K antagonists (VKA) as treatments for stroke prevention in atrial fibrillation (AF) patients. Methods The target trial approach was applied to the prospective observational Swiss-AF cohort, which enrolled 2415 AF patients from 2014 to 2017.

article thumbnail

Impact of elevated left ventricular filling pressure on long-term outcomes after transcatheter aortic valve replacement

Open Heart

Methods This was a retrospective study of all patients who underwent TAVR between 1 January 2014 and 31 December 2017. years and were more likely to be males (62%), diabetic (41% vs 35%, p=0.046), and have a higher prevalence of atrial fibrillation (Afib) (53% vs 39%, p<0.001). Patients with elevated FP had a mean age of 81.2±8.6